Aberrations in the MAPK pathway are frequently observed in various cancers. Mutations, overexpression, or persistent activation of components in this pathway can lead to uncontrolled cell growth and proliferation, a hallmark of cancer. For instance, mutations in the BRAF gene, which encodes a serine/threonine-protein kinase, are common in melanoma and other cancers.
